SEC Form 4 · accession 0001209191-17-034702
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay T Flatley
Director
Period of report
May 22, 2017
Accepted (ET)
May 23, 2017 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $24.07 | May 22, 2017 | A | 18,000 | A | — | May 21, 2027 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F11/36th of the shares subject to the option shall vest and become exercisable on June 22, 2017 and 1/36th of the shares subject to the option shall vest and become exercisable monthly thereafter.